Related Experiment Videos
The growth hormone hypothesis - 2005 revision
1Medical Research Laboratories & Medical Department M, Aarhus University Hospital, Aarhus, Denmark.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|May 27, 2005
Summary
Growth hormone (GH) and insulin-like growth factor I (IGF-I) are implicated in diabetic retinopathy development. Despite decades of research, experimental data support their role, but clinical trials show mixed results, warranting further investigation.
Area of Science:
- Endocrinology
- Ophthalmology
- Diabetology
Background:
- Growth hormone (GH) and insulin-like growth factor I (IGF-I) have been investigated for over 30 years regarding their role in diabetic retinopathy.
- Experimental evidence suggests a significant involvement of these hormones in the pathogenesis of diabetic retinopathy.
Purpose of the Study:
- To review the current literature on the potential involvement of GH and IGF-I in the development of diabetic retinopathy.
- To assess the existing evidence supporting GH and IGF-I as pathogenic agents in diabetic retinopathy.
Main Methods:
- Literature review of experimental data and clinical trials.
- Analysis of scientific publications spanning more than three decades.
Main Results:
- Substantial experimental data support a role for GH and IGF-I in diabetic retinopathy.
- Clinical trial results investigating these hormones have been variable and inconclusive.
Conclusions:
- Despite decades of research, GH and IGF-I, particularly IGF-I, remain under suspicion as key players in diabetic retinopathy.
- The scientific inquiry into the role of GH and IGF-I in diabetic retinopathy continues to be a compelling area of research.